Ferring Pharmaceuticals A/S
🇩🇰Denmark
Clinical Trials
181
Active:170
Completed:2
Trial Phases
2 Phases
Phase 1:93
Phase 3:2
Drug Approvals
20
CIMA_AEMPS:10
NMPA:7
EMA:3
Drug Approvals
Human Follitropin delta Injection
- Product Name
- 贺可唯
- Approval Number
- 国药准字SJ20240016
- Approval Date
- Apr 30, 2024
NMPA
Human Follitropin delta Injection
- Product Name
- 贺可唯
- Approval Number
- 国药准字SJ20240014
- Approval Date
- Apr 30, 2024
NMPA
Human Follitropin delta Injection
- Product Name
- 贺可唯
- Approval Number
- 国药准字SJ20240015
- Approval Date
- Apr 30, 2024
NMPA
Degarelix Acetate for Injection
- Product Name
- 注射用醋酸地加瑞克
- Approval Number
- 国药准字HJ20180053
- Approval Date
- Mar 1, 2024
NMPA
Degarelix Acetate for Injection
- Product Name
- 注射用醋酸地加瑞克
- Approval Number
- 国药准字HJ20180054
- Approval Date
- Mar 1, 2024
NMPA
Degarelix Acetate for Injection
- Product Name
- 注射用醋酸地加瑞克
- Approval Number
- H20180054
- Approval Date
- Jul 24, 2019
NMPA
Degarelix Acetate for Injection
- Product Name
- 注射用醋酸地加瑞克
- Approval Number
- H20180053
- Approval Date
- Jul 24, 2019
NMPA
Clinical Trials
Distribution across different clinical trial phases (96 trials with phase data)• Click on a phase to view related trials
Phase 1
93 (96.9%)Phase 3
2 (2.1%)1 (1.0%)
No trials found
News
No news found